Publications by authors named "Jamila B Perritt"

Objective: To develop a drug facts label prototype for a combination mifepristone and misoprostol product and to conduct a label-comprehension study to assess understanding of key label concepts.

Methods: We followed U.S.

View Article and Find Full Text PDF

Objective: We aimed to examine how peripartum contraceptive care quality improvement efforts address or perpetuate reproductive health injustices.

Study Design: We conducted a comparative case study of inpatient postpartum contraceptive care implementation in 2017 to 2018, using key informant interviews at 11 United States hospitals. After our primary analysis revealed tensions between enhancing access to contraceptive care and patient-centeredness, we conducted the current inductive content analysis guided by 4 questions developed post-hoc: (1) What are healthcare workers' aspirations for contraceptive quality improvement programs? (2) What are healthcare workers' biases regarding peripartum contraceptive care delivery? (3) Do care delivery processes center patients' needs? (4) Do healthcare workers recognize and engage with structural inequities?

Results: Seventy-eight key informants (i.

View Article and Find Full Text PDF

Diagnoses of depression, anxiety, or other mental illness capture just one aspect of the psychosocial elements of the perinatal period. Perinatal loss; trauma; unstable, unsafe, or inhumane work environments; structural racism and gendered oppression in health care and society; and the lack of a social safety net threaten the overall well-being of birthing people, their families, and communities. Developing relevant policies for perinatal mental health thus requires attending to the intersecting effects of racism, poverty, lack of child care, inadequate postpartum support, and other structural violence on health.

View Article and Find Full Text PDF

Perinatal health outcomes in the United States continue to worsen, with the greatest burden of inequity falling on Black birthing communities. Despite transdisciplinary literature citing structural racism as a root cause of inequity, interventions continue to be mostly physician-centered models of perinatal and reproductive healthcare (PRH). These models prioritize individual, biomedical risk identification and stratification as solutions to achieving equity, without adequately addressing the social and structural determinants of health.

View Article and Find Full Text PDF

We describe how mass incarceration directly undermines the core values of reproductive justice and how this affects incarcerated and nonincarcerated women.Mass incarceration, by its very nature, compromises and undermines bodily autonomy and the capacity for incarcerated people to make decisions about their reproductive well-being and bodies; this is done through institutionalized racism and is disproportionately done to the bodies of women of color. This violates the most basic tenets of reproductive justice-the right to have a child, not to have a child, and to parent the children you have with dignity and in safety.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness and side effects of using misoprostol alone versus with hygroscopic dilators for cervical preparation prior to dilation and evacuation (D&E) before 20 weeks of pregnancy.
  • A total of 163 women were randomized, with results showing that the use of hygroscopic dilators increased overall procedure time by 3.2 minutes but did not significantly shorten the actual D&E time.
  • Additionally, women taking buccal misoprostol experienced fewer chills compared to those taking vaginal misoprostol, suggesting a preference for buccal administration due to fewer side effects.
View Article and Find Full Text PDF

The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described.

View Article and Find Full Text PDF

Background: Data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS) were used to evaluate whether women with selected medical comorbidities are less likely than healthier women to report receiving contraceptive counseling during pregnancy and to report using contraception postpartum.

Methods: We analyzed de-identified data from the 2004-2007 Maryland PRAMS using logistic regression to evaluate these outcomes: undesired pregnancy, self-reported antepartum contraceptive counseling and postpartum contraceptive use for women with and without hypertension, diabetes or heart disease. Survey data were used to estimate response frequency within the Maryland birth population.

View Article and Find Full Text PDF